Lynn Seely, President and CEO at Lyell Immunopharma, Inc. (LYEL), sold 9,589 shares at $15.54 ($149K) on 2026-08-21, disclosed to the SEC on 2026-08-25.
Open-market sale of $149k LYEL by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LYEL | SELL | 2026-02-12 | $174K | — | Filing → |
| LYEL | SELL | 2026-02-11 | $10K | — | Filing → |
| LYEL | SELL | 2025-11-12 | $7K | — | Filing → |